AU516398B2

AU516398B2 – Esters of methyl-3, 4-dihydroxyphenyl alanine
– Google Patents

AU516398B2 – Esters of methyl-3, 4-dihydroxyphenyl alanine
– Google Patents
Esters of methyl-3, 4-dihydroxyphenyl alanine

Info

Publication number
AU516398B2

AU516398B2
AU30912/77A
AU3091277A
AU516398B2
AU 516398 B2
AU516398 B2
AU 516398B2
AU 30912/77 A
AU30912/77 A
AU 30912/77A
AU 3091277 A
AU3091277 A
AU 3091277A
AU 516398 B2
AU516398 B2
AU 516398B2
Authority
AU
Australia
Prior art keywords
esters
methyl
dihydroxyphenyl alanine
dihydroxyphenyl
alanine
Prior art date
1973-09-25
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)

Expired

Application number
AU30912/77A
Other versions

AU3091277A
(en

Inventor
W. S Saari
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

Merck and Co Inc

Original Assignee
Merck and Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
1973-09-25
Filing date
1977-11-23
Publication date
1981-06-04

1974-06-25
Priority to US05/482,102
priority
Critical
patent/US3983138A/en

1974-09-10
Priority to NL7412030.A
priority
patent/NL157010B/en

1974-09-16
Priority to FR7431204A
priority
patent/FR2244488B1/fr

1974-09-17
Priority to AU73366/74A
priority
patent/AU489265B2/en

1974-09-18
Priority to GB4071474A
priority
patent/GB1447599A/en

1974-09-19
Priority to CA209,616A
priority
patent/CA1057767A/en

1974-09-19
Priority to CH1273474A
priority
patent/CH606027A5/xx

1974-09-23
Priority to LU70966A
priority
patent/LU70966A1/xx

1974-09-23
Priority to OA55305A
priority
patent/OA04785A/en

1974-09-24
Priority to BE148813A
priority
patent/BE820253A/en

1974-09-24
Priority to AT767874A
priority
patent/AT343639B/en

1974-09-24
Priority to DE2445584A
priority
patent/DE2445584C3/en

1974-09-25
Priority to JP49109657A
priority
patent/JPS5062944A/ja

1975-03-21
Priority to US05/560,908
priority
patent/US4038411A/en

1975-03-21
Priority to US05/560,834
priority
patent/US4051169A/en

1976-03-18
Priority to US05/668,021
priority
patent/US4058530A/en

1977-11-23
Application filed by Merck and Co Inc
filed
Critical
Merck and Co Inc

1977-11-23
Priority to AU30912/77A
priority
patent/AU516398B2/en

1978-05-04
Publication of AU3091277A
publication
Critical
patent/AU3091277A/en

1978-07-06
Priority to US05/922,269
priority
patent/US4198413A/en

1981-06-04
Application granted
granted
Critical

1981-06-04
Publication of AU516398B2
publication
Critical
patent/AU516398B2/en

Status
Expired
legal-status
Critical
Current

Links

Espacenet

Global Dossier

Discuss

Classifications

C—CHEMISTRY; METALLURGY

C07—ORGANIC CHEMISTRY

C07D—HETEROCYCLIC COMPOUNDS

C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom

C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom

C07D207/30—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members

C07D207/34—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms

C07D207/36—Oxygen or sulfur atoms

C07D207/40—2,5-Pyrrolidine-diones

C07D207/404—2,5-Pyrrolidine-diones with only hydrogen atoms or radicals containing only hydrogen and carbon atoms directly attached to other ring carbon atoms, e.g. succinimide

A—HUMAN NECESSITIES

A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE

A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS

A61P9/00—Drugs for disorders of the cardiovascular system

A61P9/12—Antihypertensives

C—CHEMISTRY; METALLURGY

C07—ORGANIC CHEMISTRY

C07D—HETEROCYCLIC COMPOUNDS

C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom

C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom

C07D207/44—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having three double bonds between ring members or between ring members and non-ring members

C—CHEMISTRY; METALLURGY

C07—ORGANIC CHEMISTRY

C07D—HETEROCYCLIC COMPOUNDS

C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom

C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom

C07D207/44—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having three double bonds between ring members or between ring members and non-ring members

C07D207/444—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having three double bonds between ring members or between ring members and non-ring members having two doubly-bound oxygen atoms directly attached in positions 2 and 5

C07D207/448—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having three double bonds between ring members or between ring members and non-ring members having two doubly-bound oxygen atoms directly attached in positions 2 and 5 with only hydrogen atoms or radicals containing only hydrogen and carbon atoms directly attached to other ring carbon atoms, e.g. maleimide

C07D207/452—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having three double bonds between ring members or between ring members and non-ring members having two doubly-bound oxygen atoms directly attached in positions 2 and 5 with only hydrogen atoms or radicals containing only hydrogen and carbon atoms directly attached to other ring carbon atoms, e.g. maleimide with hydrocarbon radicals, substituted by hetero atoms, directly attached to the ring nitrogen atom

C—CHEMISTRY; METALLURGY

C07—ORGANIC CHEMISTRY

C07D—HETEROCYCLIC COMPOUNDS

C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom

C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring

C07D209/44—Iso-indoles; Hydrogenated iso-indoles

C07D209/48—Iso-indoles; Hydrogenated iso-indoles with oxygen atoms in positions 1 and 3, e.g. phthalimide

C—CHEMISTRY; METALLURGY

C07—ORGANIC CHEMISTRY

C07D—HETEROCYCLIC COMPOUNDS

C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings

C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom

C07D211/80—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members

C07D211/84—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen directly attached to ring carbon atoms

C07D211/86—Oxygen atoms

C07D211/88—Oxygen atoms attached in positions 2 and 6, e.g. glutarimide

C—CHEMISTRY; METALLURGY

C07—ORGANIC CHEMISTRY

C07D—HETEROCYCLIC COMPOUNDS

C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members

C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members

C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom

C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms

C07D213/78—Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals

C07D213/81—Amides; Imides

C07D213/82—Amides; Imides in position 3

C—CHEMISTRY; METALLURGY

C07—ORGANIC CHEMISTRY

C07D—HETEROCYCLIC COMPOUNDS

C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings

C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members

C07D233/64—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms, e.g. histidine

C—CHEMISTRY; METALLURGY

C07—ORGANIC CHEMISTRY

C07D—HETEROCYCLIC COMPOUNDS

C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings

C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members

C07D233/66—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms

C—CHEMISTRY; METALLURGY

C07—ORGANIC CHEMISTRY

C07D—HETEROCYCLIC COMPOUNDS

C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings

C07D263/02—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings

C07D263/30—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members

C07D263/34—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms

C07D263/44—Two oxygen atoms

C—CHEMISTRY; METALLURGY

C07—ORGANIC CHEMISTRY

C07D—HETEROCYCLIC COMPOUNDS

C07D275/00—Heterocyclic compounds containing 1,2-thiazole or hydrogenated 1,2-thiazole rings

C07D275/04—Heterocyclic compounds containing 1,2-thiazole or hydrogenated 1,2-thiazole rings condensed with carbocyclic rings or ring systems

C07D275/06—Heterocyclic compounds containing 1,2-thiazole or hydrogenated 1,2-thiazole rings condensed with carbocyclic rings or ring systems with hetero atoms directly attached to the ring sulfur atom

C—CHEMISTRY; METALLURGY

C07—ORGANIC CHEMISTRY

C07D—HETEROCYCLIC COMPOUNDS

C07D317/00—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms

C07D317/08—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3

C07D317/44—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 ortho- or peri-condensed with carbocyclic rings or ring systems

C07D317/46—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 ortho- or peri-condensed with carbocyclic rings or ring systems condensed with one six-membered ring

C07D317/48—Methylenedioxybenzenes or hydrogenated methylenedioxybenzenes, unsubstituted on the hetero ring

C07D317/50—Methylenedioxybenzenes or hydrogenated methylenedioxybenzenes, unsubstituted on the hetero ring with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to atoms of the carbocyclic ring

C07D317/60—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals

AU30912/77A
1973-09-25
1977-11-23
Esters of methyl-3, 4-dihydroxyphenyl alanine

Expired

AU516398B2
(en)

Priority Applications (18)

Application Number
Priority Date
Filing Date
Title

US05/482,102

US3983138A
(en)

1973-09-25
1974-06-25
Amino acid esters

NL7412030.A

NL157010B
(en)

1973-09-25
1974-09-10

PROCESS FOR PREPARING ANTI-HYPERTENSIVELY ACTIVE ESTERS OF ALPHA-METHYL-3,4-DIHYDROXYPHENYLALANINE AND ACYL DERIVATIVES THEREOF; PROCESS FOR PREPARING PHARMACEUTICAL PREPARATIONS; AS WELL AS THE MOLDED PRODUCTS OBTAINED THROUGH THE APPLICATION.

FR7431204A

FR2244488B1
(en)

1973-09-25
1974-09-16

AU73366/74A

AU489265B2
(en)

1974-09-17
Esters of methyl-3, 4-dihydroxyphenylalanine

GB4071474A

GB1447599A
(en)

1973-09-25
1974-09-18
Derivatives of alpha-methyldopa

CA209,616A

CA1057767A
(en)

1973-09-25
1974-09-19
Amino acid esters

CH1273474A

CH606027A5
(en)

1973-09-25
1974-09-19

OA55305A

OA04785A
(en)

1973-09-25
1974-09-23

Amino acid esters.

LU70966A

LU70966A1
(en)

1973-09-25
1974-09-23

DE2445584A

DE2445584C3
(en)

1973-09-25
1974-09-24

L- or DL-2-methyl-3- (3 ‘, 4′-dihydroxyphenyl) alanine esters, processes for their preparation and pharmaceuticals containing these compounds

BE148813A

BE820253A
(en)

1973-09-25
1974-09-24

AMINO ACID ESTERS

AT767874A

AT343639B
(en)

1973-09-25
1974-09-24

PROCESS FOR THE PREPARATION OF NEW RACEMIC OR OPTICALLY ACTIVE 3,4-DIHYDROXYPHENYL-ALFA-METHYLALANINE ESTERS AND THEIR ACID ADDITION SALTS

JP49109657A

JPS5062944A
(en)

1973-09-25
1974-09-25

US05/560,908

US4038411A
(en)

1973-09-25
1975-03-21
Antihypertensive amino acid esters

US05/560,834

US4051169A
(en)

1973-09-25
1975-03-21
Amino acid esters

US05/668,021

US4058530A
(en)

1973-09-25
1976-03-18
Amino acid esters

AU30912/77A

AU516398B2
(en)

1973-09-25
1977-11-23
Esters of methyl-3, 4-dihydroxyphenyl alanine

US05/922,269

US4198413A
(en)

1973-09-25
1978-07-06
Amino acid esters

Applications Claiming Priority (3)

Application Number
Priority Date
Filing Date
Title

US40060973A

1973-09-25
1973-09-25

US05/482,102

US3983138A
(en)

1973-09-25
1974-06-25
Amino acid esters

AU30912/77A

AU516398B2
(en)

1973-09-25
1977-11-23
Esters of methyl-3, 4-dihydroxyphenyl alanine

Related Child Applications (1)

Application Number
Title
Priority Date
Filing Date

AU73366/74A
Division

AU489265B2
(en)

1974-09-17
Esters of methyl-3, 4-dihydroxyphenylalanine

Publications (2)

Publication Number
Publication Date

AU3091277A

AU3091277A
(en)

1978-05-04

AU516398B2
true

AU516398B2
(en)

1981-06-04

Family
ID=27153356
Family Applications (1)

Application Number
Title
Priority Date
Filing Date

AU30912/77A
Expired

AU516398B2
(en)

1973-09-25
1977-11-23
Esters of methyl-3, 4-dihydroxyphenyl alanine

Country Status (13)

Country
Link

US
(1)

US3983138A
(en)

JP
(1)

JPS5062944A
(en)

AT
(1)

AT343639B
(en)

AU
(1)

AU516398B2
(en)

BE
(1)

BE820253A
(en)

CA
(1)

CA1057767A
(en)

CH
(1)

CH606027A5
(en)

DE
(1)

DE2445584C3
(en)

FR
(1)

FR2244488B1
(en)

GB
(1)

GB1447599A
(en)

LU
(1)

LU70966A1
(en)

NL
(1)

NL157010B
(en)

OA
(1)

OA04785A
(en)

Families Citing this family (25)

* Cited by examiner, † Cited by third party

Publication number
Priority date
Publication date
Assignee
Title

US4198413A
(en)

*

1973-09-25
1980-04-15
Merck & Co., Inc.
Amino acid esters

SE7605911L
(en)

*

1975-06-11
1976-12-12
Merck & Co Inc

IMPROVED PROCEDURE FOR MAKING ESTRARS OF ALFA-METHYL-3,4-DIHYDROXYPHENYLALANINE

FR2365341A1
(en)

*

1976-09-28
1978-04-21
Synthelabo

L- (PHENYL-3 AMINO-2 PROPIONYLOXY) -2 ACETIC DERIVATIVES

US4120971A
(en)

*

1977-03-01
1978-10-17
Merck & Co., Inc.
Novel N-carboxy-alpha-amino acid anhydrides

GB1583602A
(en)

*

1977-05-26
1981-01-28
Sterwin Ag
N-acetyl-para-aminophenyl-n’-acetyl-amino-thioalkanoic acid ester derivatives

US4401676A
(en)

*

1977-06-01
1983-08-30
Merck & Co., Inc.
Novel α-amino acids

US4271187A
(en)

*

1978-06-05
1981-06-02
Merck & Co., Inc.
Substituted phenyl alanine antihypertensive agents

IL57609A
(en)

*

1979-06-21
1983-05-15
Yeda Res & Dev
Pharmaceutical compositions for the treatment of sickle cell disease comprising p-nitrobenzyl esters or amides of aromatic or hydrophobic aminoacids

US4404392A
(en)

*

1981-11-16
1983-09-13
Merck & Co., Inc.
Resolution of α-pivaloyloxyethyl-(S)-3-(3,4-dihydroxyphenyl)-2-methylalantinate into its α and β isomers

US4360533A
(en)

*

1981-12-14
1982-11-23
Merck & Co., Inc.
Glyceryl ester of 1-methyl-2-(3,4-dihydroxyphenyl)alanine

US4440942A
(en)

*

1982-03-01
1984-04-03
Merck & Co., Inc.
Crystalline diastereomeric L-alpha-methyldopa POE ester and process for its preparation

US4670578A
(en)

*

1983-08-29
1987-06-02
Merck & Co., Inc.
Process for crystalline salts of L or (S)-3-(3,4-dihydroxyphenyl)-2-methylalanine esters

US4914222A
(en)

*

1983-08-29
1990-04-03
Merck & Co., Inc.
Crystalline salts of L or (S)-3-(3,4-dihydroxyphenyl)-2-methylalanine esters and process

IL72726A
(en)

*

1983-08-29
1988-02-29
Merck & Co Inc
Crystalline salts of(s)-3-(3,4-dihydroxyphenyl)-2-methylalanine esters with(r,s)1-pivaloyloxyethanol,their preparation and pharmaceutical compositions containing them

JPH02138A
(en)

*

1987-09-18
1990-01-05
Banyu Pharmaceut Co Ltd
L-dopa derivative

WO2005121069A1
(en)

*

2004-06-04
2005-12-22
Xenoport, Inc.
Levodopa prodrugs, and compositions and uses thereof

KR101396639B1
(en)

2005-12-05
2014-05-21
제노포트 인코포레이티드
Levodopa prodrug mesylate, compositions thereof, and uses thereof

US7829592B2
(en)

2006-12-21
2010-11-09
Xenoport, Inc.
Catechol protected levodopa diester prodrugs, compositions, and methods of use

TW200843732A
(en)

2006-12-21
2008-11-16
Xenoport Inc
Levodopa dimethyl-substituted diester prodrugs, compositions, and methods of use

CA2740017A1
(en)

2008-10-20
2010-04-29
Xenoport, Inc.
Methods of synthesizing a levodopa ester prodrug

US8399513B2
(en)

2008-10-20
2013-03-19
Xenoport, Inc.
Levodopa prodrug mesylate hydrate

EP3461855B1
(en)

*

2009-10-11
2020-05-27
Rutgers, The State University of New Jersey
Biocompatible polymers for medical devices

EP2515876B1
(en)

2009-11-09
2016-01-06
XenoPort, Inc.
Pharmaceutical compositions and oral dosage forms of a levodopa prodrug and methods of use

CN103694127B
(en)

*

2013-12-30
2015-04-01
上海交通大学
Compound produced by Streptomyces labedae, as well as preparation method and application of compound

CN113176369B
(en)

*

2021-04-09
2022-05-31
浙江省海洋生态环境监测中心
Method for determining organic tin in marine shellfish product

1974

1974-06-25
US
US05/482,102
patent/US3983138A/en
not_active
Expired – Lifetime

1974-09-10
NL
NL7412030.A
patent/NL157010B/en
not_active
IP Right Cessation

1974-09-16
FR
FR7431204A
patent/FR2244488B1/fr
not_active
Expired

1974-09-18
GB
GB4071474A
patent/GB1447599A/en
not_active
Expired

1974-09-19
CH
CH1273474A
patent/CH606027A5/xx
not_active
IP Right Cessation

1974-09-19
CA
CA209,616A
patent/CA1057767A/en
not_active
Expired

1974-09-23
OA
OA55305A
patent/OA04785A/en
unknown

1974-09-23
LU
LU70966A
patent/LU70966A1/xx
unknown

1974-09-24
BE
BE148813A
patent/BE820253A/en
not_active
IP Right Cessation

1974-09-24
DE
DE2445584A
patent/DE2445584C3/en
not_active
Expired

1974-09-24
AT
AT767874A
patent/AT343639B/en
not_active
IP Right Cessation

1974-09-25
JP
JP49109657A
patent/JPS5062944A/ja
active
Pending

1977

1977-11-23
AU
AU30912/77A
patent/AU516398B2/en
not_active
Expired

Also Published As

Publication number
Publication date

CA1057767A
(en)

1979-07-03

CH606027A5
(en)

1978-10-13

DE2445584C3
(en)

1979-05-10

AT343639B
(en)

1978-06-12

FR2244488A1
(en)

1975-04-18

ATA767874A
(en)

1977-10-15

US3983138A
(en)

1976-09-28

BE820253A
(en)

1975-03-24

NL7412030A
(en)

1975-03-27

AU7336674A
(en)

1976-03-25

JPS5062944A
(en)

1975-05-29

OA04785A
(en)

1980-08-31

FR2244488B1
(en)

1978-06-30

LU70966A1
(en)

1975-06-16

NL157010B
(en)

1978-06-15

GB1447599A
(en)

1976-08-25

DE2445584A1
(en)

1975-03-27

AU3091277A
(en)

1978-05-04

DE2445584B2
(en)

1978-08-31

Similar Documents

Publication
Publication Date
Title

AU516398B2
(en)

1981-06-04

Esters of methyl-3, 4-dihydroxyphenyl alanine

AU474137B2
(en)

1976-07-15

Auto-refractometer

AU468964B2
(en)

1976-01-29

Melik

CA1033572A
(en)

1978-06-27

Bunker-boiler installations

CA1010130A
(en)

1977-05-10

Terminating ribbon-conductors

AU498889B2
(en)

1979-03-29

Piperidylene benzocycloheptathiophenes

AU476397B2
(en)

1976-09-16

A-cycloalkylbenzyl lactamimides

AU476505B2
(en)

1976-09-23

Alkylbenxyl lactamimides

AU472907B2
(en)

1976-06-10

Firecheck

CA1011527A
(en)

1977-06-07

Anchor assembly

AU476386B2
(en)

1976-09-16

Dibenzocycloheptenyl lactamimides

AU471241B2
(en)

1976-04-15

Benzothiazolylureas

AU489265B2
(en)

1976-03-25

Esters of methyl-3, 4-dihydroxyphenylalanine

AU486223B2
(en)

1976-05-06

New esters

AU477508B2
(en)

1974-11-02

Anchor

CA1000517A
(en)

1976-11-30

2-chloroethylphosphonodithloate esters

AU483241B2
(en)

1975-05-22

Substituted acylanilides

CA949365A
(en)

1974-06-18

Jacketed dental anchor

AU480521B2
(en)

1976-04-15

Bunker-boiler installations

AU489560B2
(en)

1976-01-15

Amidinoureas

AU479426B2
(en)

1975-08-21

Carbothiolates

AU490583B2
(en)

4-aryl-5-aminoalkyl-4-oxazolin-2-ones

AU491458B2
(en)

1976-06-24

7-halomethyl-17-hydroxy-3-oxo-17 -pregn-4-ene-21-carboxylic acid -lactones

AU482276B2
(en)

1976-04-08

Spiro-cyclopropanes

AU482530B2
(en)

1974-07-25

Benzocycloheptathiophenes

Download PDF in English

None